The Association of Trefoil Factors with Gastric Cancer and Premalignant Lesions: A Cross-Sectional Population-Based Cohort Study
Authors:
- 1 March 2022
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 31 (3) , 625-632
Abstract
Background: A lack of research on the association of trefoil factors (TFF) with gastric cancer and premalignant lesions (PML) in the general population is an important obstacle to the application of TFFs for gastric cancer screening. We aimed to analyze the association of TFFs with gastric cancer and PMLs in a general population. Methods: We evaluated 3,986 adults residing in Wuwei, China. We collected baseline characteristics and gastric cancer risk factors, including TFFs, endoscopic diagnosis, and pathologic information. Three logistic regression models were generated to analyze the association between TFFs and gastric cancer, as well as PMLs. Adjusted odds ratio (OR) and 95% confidence intervals (95% CI) were calculated to determine the strength of association. Results: Compared with pepsinogen (PG) and anti–Helicobacter pylori immunoglobulin G antibody (Hp-IgG), TFFs had significant association with gastric cancer and PMLs after adjusting for biomarkers and risk factors (P < 0.05). The ORs (95% CI) for TFF1 (1.67; 1.27–2.20), TFF2 (2.66; 2.01–3.51), and TFF3 (1.32; 1.00–1.74) were larger than the ORs for PGI (0.79; 0.61–1.03), PGI/II (1.00; 0.76–1.31), and Hp-IgG (0.99; 0.73–1.35) in the gastric cancer group. In the intestinal metaplasia (IM) group, not only the TFF3 serum level was the highest, but also the OR (1.92; 1.64–2.25) was the highest. Conclusions: TFFs were associated with risk of gastric cancer and PMLs. Impact: Serum TFFs can improve the screening of high-risk populations for gastric cancer.Keywords
All Related Versions
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2012GS620101)
This publication has 37 references indexed in Scilit:
- The gastric precancerous cascadeJournal of Digestive Diseases, 2011
- Tests for Serum Levels of Trefoil Factor Family Proteins Can Improve Gastric Cancer ScreeningGastroenterology, 2011
- Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - "ABC method"Proceedings of the Japan Academy, Series B, 2011
- Are trefoil factors oncogenic?Trends in Endocrinology & Metabolism, 2008
- Trefoil Factor Family-1 Mutations Enhance Gastric Cancer Cell Invasion Through Distinct Signaling PathwaysGastroenterology, 2006
- Trefoil factor family-3 is associated with aggressive behavior of colon cancer cellsClinical & Experimental Metastasis, 2005
- Trefoil factor 1 is required for the commitment programme of mouse oxyntic epithelial progenitorsGut, 2004
- Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non‐neoplastic gastric tissuesThe Journal of Pathology, 2002
- The Three Human Trefoil Genes TFF1, TFF2, and TFF3 Are Located within a Region of 55 kb on Chromosome 21q22.3Genomics, 1997
- The Gene Encoding Human Intestinal Trefoil Factor (TFF3) Is Located on Chromosome 21q22.3 Clustered with Other Members of the Trefoil Peptide FamilyGenomics, 1996